Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Pembrolizumab Enhances the Anti-Leukemia Activity of Antigen Specific Cytotoxic T Lymphocytes

Mao Zhang, MPH, Pariya Sukhumalchandra, BS, Anne V. Philips, PhD, Na Qiao, PhD, Celine Kerros, PhD, Lisa St. John, PhD, Alexander A. Perakis, BS, Karen Clise-Dwyer, PhD, Elizabeth Mittendorf, MD PhD, Naval G. Daver, MD, Jeffrey J. Molldrem, MD, Qing Ma, PhD, Gheath Alatrash, DO, PhD

Blood (2018) 132 (Supplement 1): 4542.

https://doi.org/10.1182/blood-2018-99-114864

Published: 2018

Journal Articles

Influence of the Intensity of the Conditioning Regimens on the Risks of Gvhd in Patients Receiving Rituximab Prophylaxis during Allogeneic Stem Cell Transplantation (alloSCT)

Issa F. Khouri, Denái R. Milton, Celina Ledesma, Elias J. Jabbour, MD, Gheath Alatrash, DO, PhD, Paolo Anderlini, MD, Amin M. Alousi, MD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Sharon Hymes, BS, MD, David Marin, MD, Jeffrey J. Molldrem, MD, Amanda L. Olson, MD, Betul Oran, MDMS, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Gabriela Rondon, MD, Richard E Champlin, MD, Alison Gulbis

Blood (2018) 132 (Supplement 1): 4584.

https://doi.org/10.1182/blood-2018-99-112990

Published: 2018

Journal Articles

Durability Results of Non-Myeloablative (NMA) Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed Follicular Lymphoma: 17- Year Experience

Blood (2018) 132 (Supplement 1): 4651.

https://doi.org/10.1182/blood-2018-99-117767

Published: 2018

Journal Articles

Hypomethylating Agent Leads to Enhanced Immunogenicity of a Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine and Prolonged Survival in an Immunocompetent Mouse Model

Myrna R. Nahas, MD, Leandra Cole, Dina Stroopinsky, PhD, Anna Sergeeva, PhD, Athalia Rachel Pyzer, MD PhD, Abigail J. Washington, Malgorzata McMasters, MD, James D. Levine, MD MS, Matthew Weinstock, MD, Shira Orr, PhD, Adam Ephraim, Jeffrey J. Molldrem, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD

Blood (2017) 130 (Supplement 1): 1347.

https://doi.org/10.1182/blood.V130.Suppl_1.1347.1347

Published: 2017

Journal Articles

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Jefferson L. Lansford, BS, Udara Dharmasiri, PhD, Shengjie Chai, BS, Sally A. Hunsucker, PhD, Dante S. Bortone, PhD, James E. Keating, BS, Ian M. Schlup, Gary L. Glish, PhD, Edward J. Collins, PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2017) 130 (Supplement 1): 207.

https://doi.org/10.1182/blood.V130.Suppl_1.207.207

Published: 2017

Journal Articles

Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia

Selena Carmona, MS, Celine Kerros, PhD, Alexander Perakis, Anne Philip, Pariya Sukhumalchandra, Anna Sergeeva, PhD, Lisa St. John, Mao Zhang, MPH, Na Qiao, Elizabeth Mittendorf, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD

Blood (2017) 130 (Supplement 1): 3596.

https://doi.org/10.1182/blood.V130.Suppl_1.3596.3596

Published: 2017

Journal Articles

Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia

Eran Tallis, Sijie Lu, PhD, Xiaoling Ding, Dan Li, PhD, Kathryn Ruisaard, M. James You, MD PhD, Lisa St. John, Gheath Alatrash, DO, PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD

Blood (2017) 130 (Supplement 1): 4460.

https://doi.org/10.1182/blood.V130.Suppl_1.4460.4460

Published: 2017

Journal Articles

Cathepsin G Is Expressed By B Cell Acute Lymphoblastic Leukemia and Is an Effective Immunotherapeutic Target

Maliha Khan, Selena Carmona, MS, Pariya Sukhumalchandra, Yihua Qiu, Alexander Perakis, Mao Zhang, MPH, Madhushree Zope, Anne Philip, Abdul Shah, Na Qiao, Lisa St. John, Jonathan Goldberg, Elizabeth Mittendorf, Jeffrey J. Molldrem, MD, Steven Kornblau, MD, Gheath Alatrash, DO, PhD

Blood (2017) 130 (Supplement 1): 1438.

https://doi.org/10.1182/blood.V130.Suppl_1.1438.1438

Published: 2017

Journal Articles

Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow

Mikhail Kolonin, PhD, Anna Sergeeva, PhD, Daniela Staquicini, PhD, Jeffrey J. Molldrem, MD, Renata Pasqualini, PhD, Wadih Arap, MD PhD

Blood (2016) 128 (22): 1025.

https://doi.org/10.1182/blood.V128.22.1025.1025

Published: 2016

Journal Articles

Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Jefferson L. Lansford, Shengjie Chai, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD PhD, Benjamin G. Vincent, MD

Blood (2016) 128 (22): 3352.

https://doi.org/10.1182/blood.V128.22.3352.3352

Published: 2016

Journal Articles

Cross-Presentation Is a Source of Tumor Antigens for Multiple Myeloma Immunotherapy

Alexander A. Perakis, BA, Haley L. Peters, PhD, Jason Roszik, PhD, Mao Zhang, MPH, Anna Sergeeva, PhD, Celine Kerros, PhD, Pariya Sukhumalchandra, BS, Anne V. Philips, PhD, Maria R. Khouri, Rahul U. Popat, Lisa St. John, PhD, Amjad Talukder, PhD, David H. Hawke, PhD, Greg Lizee, PhD, Elizabeth A. Mittendorf, MD PhD, Jeffrey J. Molldrem, MD, Gheath Alatrash, DO, PhD

Blood (2016) 128 (22): 2104.

https://doi.org/10.1182/blood.V128.22.2104.2104

Published: 2016

Journal Articles

Humanized Anti-PR1/HLA-A2 T Cell Receptor-like Monoclonal Antibody, h8F4, Has Multiple Effector Mechanisms

Anna Sergeeva, PhD, Hong He, MD, Kathryn Cox, Lisa St John, PhD, Mei Sang, Celine Kerros, PhD, Qiaochuan Li, PhD MD, Amanda Herrmann, Karen Clise-Dwyer, PhD, Qing Ma, PhD, Gregory Lizee, PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD

Blood (2016) 128 (22): 4061.

https://doi.org/10.1182/blood.V128.22.4061.4061

Published: 2016

Journal Articles

Ibrutinib Treatment Modulates T Cell Activation and Polarization in Immune Response

Dan Li, PhD, Patenia Rebecca, BS, Roza Nurieva, PhD, Jeffrey J. Molldrem, MD, Richard E. Champlin, MD, Qing Ma, PhD

Blood (2015) 126 (23): 3435.

https://doi.org/10.1182/blood.V126.23.3435.3435

Published: 2015

Journal Articles

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Aaron C. Logan, MDPhD, Alex F. Herrera, MD, Christine E. Ryan, Andrew R. Rezvani, MD, Katherine A. Kong, PhD, Malek Faham, MD PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Rachel L. Sargent, MD, Edwin P. Alyea, MD, Vincent T. Ho, MD, Jennifer R. Brown, MD PhD, Jerome Ritz, MD, David B. Miklos, MD PhD

Blood (2015) 126 (23): 4340.

https://doi.org/10.1182/blood.V126.23.4340.4340

Published: 2015

Journal Articles

A Bayesian, Phase II Randomized Trial of Extracorporeal Photopheresis (ECP) Plus Steroids Versus Steroids-Alone in Patients with Newly Diagnosed Acute Graft Vs. Host Disease (GVHD): The Addition of ECP Improves Gvhd Response and the Ability to Taper Steroids

Blood (2015) 126 (23): 854.

https://doi.org/10.1182/blood.V126.23.854.854

Published: 2015

Journal Articles

Intermediate Filament (IF) Protein Vimentin Regulates T Cell Mediated Immune Response in Gvhd

Dan Li, PhD, Patenia Rebecca, BS, Miguel A. Cruz, PhD, Jeffrey J. Molldrem, MD, Richard E. Champlin, MD, Qing Ma, PhD

Blood (2015) 126 (23): 3073.

https://doi.org/10.1182/blood.V126.23.3073.3073

Published: 2015

Journal Articles

Fucosylated Antigen-Specific Cytotoxic T Lymphocytes Demonstrate Enhanced Killing of Leukemia Targets

Gheath Alatrash, DO, PhD, Mao Zhang, MPH, Na Qiao, PhD, Pariya Sukhumalchandra, BS, Madhushree Zope, Anne V. Philips, PhD, Alexander Perakis, BA, Lisa St. John, PhD, Maria R. Khouri, Victor Gall, MD, Karen C. Dwyer, PhD, Jodie Polan, MS, Jeffrey J. Molldrem, MD, Elizabeth J. Shpall, MD, Elizabeth A. Mittendorf, MD PhD

Blood (2015) 126 (23): 1888.

https://doi.org/10.1182/blood.V126.23.1888.1888

Published: 2015

Journal Articles

Inhibition of T Cell Proliferation By Granulocyte Membrane-Associated Proteinase 3 Is Reversed By Blocking the Interaction of Calreticulin with LRP on T Cells

Tian-Hui Yang, PhD, Lisa S. St. John, PhD, Karen Clise-Dwyer, PhD, Kathryn Ruisaard, MS, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD

Blood (2014) 124 (21): 4110.

https://doi.org/10.1182/blood.V124.21.4110.4110

Published: 2014

Journal Articles

Serum miRNA Expression and Allogeneic Stem Cell Transplantation in Patients with B Chronic Lymphocytic Leukemia (CLL)

Issa F. Khouri, MD, Simone Anfossi, PhD, Rima M Saliba, PhD, Lisa S. St. John, PhD, Jeffrey J. Molldrem, MD, James M Reuben, PhD

Blood (2014) 124 (21): 5791.

https://doi.org/10.1182/blood.V124.21.5791.5791

Published: 2014

Journal Articles

PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Celine Kerros, PhD, Anna Sergeeva, PhD, Amanda Cernosek, BS, Haroon Jakher, BS, Madhushree Zope, Rebecca Patenia, MS, Lisa St John, PhD, Alexander Perakis, BA, Karen Dwyer, PhD, Ken H. Young, MD PhD, Jinsheng Weng, PhD, Sijie Lu, PhD, Elizabeth A. Mittendorf, MD PhD, Larry W Kwak, MD PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD

Blood (2014) 124 (21): 2133.

https://doi.org/10.1182/blood.V124.21.2133.2133

Published: 2014

NARROW

Pembrolizumab Enhances the Anti-Leukemia Activity of Antigen Specific Cytotoxic T Lymphocytes

Influence of the Intensity of the Conditioning Regimens on the Risks of Gvhd in Patients Receiving Rituximab Prophylaxis during Allogeneic Stem Cell Transplantation (alloSCT)

Durability Results of Non-Myeloablative (NMA) Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed Follicular Lymphoma: 17- Year Experience

Hypomethylating Agent Leads to Enhanced Immunogenicity of a Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine and Prolonged Survival in an Immunocompetent Mouse Model

Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry

Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia

Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia

Cathepsin G Is Expressed By B Cell Acute Lymphoblastic Leukemia and Is an Effective Immunotherapeutic Target

Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow

Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Cross-Presentation Is a Source of Tumor Antigens for Multiple Myeloma Immunotherapy

Humanized Anti-PR1/HLA-A2 T Cell Receptor-like Monoclonal Antibody, h8F4, Has Multiple Effector Mechanisms

Ibrutinib Treatment Modulates T Cell Activation and Polarization in Immune Response

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

A Bayesian, Phase II Randomized Trial of Extracorporeal Photopheresis (ECP) Plus Steroids Versus Steroids-Alone in Patients with Newly Diagnosed Acute Graft Vs. Host Disease (GVHD): The Addition of ECP Improves Gvhd Response and the Ability to Taper Steroids

Intermediate Filament (IF) Protein Vimentin Regulates T Cell Mediated Immune Response in Gvhd

Fucosylated Antigen-Specific Cytotoxic T Lymphocytes Demonstrate Enhanced Killing of Leukemia Targets

Inhibition of T Cell Proliferation By Granulocyte Membrane-Associated Proteinase 3 Is Reversed By Blocking the Interaction of Calreticulin with LRP on T Cells

Serum miRNA Expression and Allogeneic Stem Cell Transplantation in Patients with B Chronic Lymphocytic Leukemia (CLL)

PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only